Evidence map›Paper›PMID 32236627›Full record

ArticleInternational journal of oncology2020

Quantitative proteomic analysis of the association between decreasing O‑GlcNAcylation and metastasis in MCF‑7 breast cancer cells.

Pukkavadee Netsirisawan, Daranee Chokchaichamnankit, Kittirat Saharat, Chantragan Srisomsap, Jisnuson Svasti, Voraratt Champattanachai

Open access · hybridAbstract read
In one paragraph

Article in International journal of oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. MitochondrialCancers · 2021
    Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Pukkavadee NetsirisawanLaboratory of Biochemistry, Chulabhorn Research Institue, Bangkok 10210, Thailand.
Daranee ChokchaichamnankitLaboratory of Biochemistry, Chulabhorn Research Institue, Bangkok 10210, Thailand.
Kittirat SaharatLaboratory of Biochemistry, Chulabhorn Research Institue, Bangkok 10210, Thailand.
Chantragan SrisomsapLaboratory of Biochemistry, Chulabhorn Research Institue, Bangkok 10210, Thailand.
Jisnuson SvastiLaboratory of Biochemistry, Chulabhorn Research Institue, Bangkok 10210, Thailand.
Voraratt ChampattanachaiLaboratory of Biochemistry, Chulabhorn Research Institue, Bangkok 10210, Thailand.
Chulabhorn Research Institute · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer is the most common type of cancer and leading cause of cancer‑associated mortality in women worldwide. O‑linked N‑acetyl glucosaminylation (O‑GlcNAcylation) is a dynamic post‑translational modification of nuclear, cytoplasmic and mitochondrial proteins. Mounting evidence suggests that abnormal O‑GlcNAcylation status is associated with cancer malignancy. In our previous study, it was reported that O‑GlcNAc and O‑GlcNAc transferase (OGT; an enzyme responsible for the addition of O‑GlcNAc) were upregulated in breast cancer tissues and cells. Moreover, O‑GlcNAcylation was required for resistance to anoikis and the anchorage‑independent growth of breast cancer cells. However, the precise roles of this modification on the development of malignancy are yet to be elucidated. Therefore, in the present study, the effects of inhibiting O‑GlcNAc on the malignant transformation of MCF‑7 breast cancer cells under different culture conditions were determined, using monolayer (primary growth), anoikis resistance (spheroid growth) and reseeding (secondary growth) to mimic the metastatic process. Decreasing O‑GlcNAc levels using small interfering (si)RNA targeting OGT resulted in a reduction in cell viability and invasiveness in anoikis resistant and reseeding conditions. Furthermore, gel‑free quantitative proteomics was performed to identify the proteins affected by a reduction of O‑GlcNAc. A total of 317 proteins were identified and compared, and the expression of 162 proteins was altered >1.5 fold in the siOGT treated cells compared with the siScamble (siSC) treated cells. Notably, 100 proteins involved in cellular metabolism, cellular localization, stress responses and gene expression were significantly altered in the reseeding condition. Among these differentially expressed proteins, the levels of small nuclear ribonucleoprotein Sm D1 exhibited the largest decrease in expression following knockdown of OGT, and this reduction in expression was associated with a significant decrease in the levels of mTOR expression, a protein which promotes tumor growth and progression. Taken together, the results of the present study demonstrate that decreasing O‑GlcNAcylation altered protein expression, and ultimately influenced the metastatic processes, particulary regarding the invasion and reattached growth of MCF‑7 breast cancer cells.

Indexed as

Protein Interaction MapsAcetylationAnoikisBreast NeoplasmsCell MovementCell ProliferationChromatography, LiquidFemaleHumansMass SpectrometryMCF-7 CellsN-AcetylglucosaminyltransferasesNeoplasm MetastasisProteomicsRNA, Small InterferingN-AcetylglucosaminyltransferasesOGT protein, humanRNA, Small Interferingbreast cancermetastasisO-GlcNAcylationprotein networkingquantitative proteomics

Identifiers

PMID32236627
PMCPMC7170043
OpenAlexW3012108646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.